Ongoing Research Shows Promising Results for Neoadjuvant Treatment for Colorectal Cancer – Advances in Gastroenterology & Oncology | NewYork-Presbyterian
A phase 2 trial led by a NewYork-Presbyterian/Weill Cornell Medicine oncologist reveals the efficacy of neoadjuvant botensilimab plus balstilimab in patients with colorectal cancer.